(Q39613098)

13 September 2017

title

The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on uveal melanoma rabbit model (English)

1 reference

13 September 2017

1 reference

ChEBI release 2020-05-28

1 reference

Ugur Ozerdem

1

1 reference

13 September 2017

Beata Mach-Hofacre

2

1 reference

13 September 2017

Nissi Varki

3

1 reference

13 September 2017

Robert Folberg

4

1 reference

13 September 2017

Arthur J Mueller

5

1 reference

13 September 2017

Renata Ochabski

6

1 reference

13 September 2017

Tony Pham

7

1 reference

13 September 2017

Krzysztof Appelt

8

1 reference

13 September 2017

William R Freeman

9

1 reference

13 September 2017

publication date

1 February 2002

1 reference

13 September 2017

1 reference

13 September 2017

volume

24

1 reference

13 September 2017

issue

2

1 reference

13 September 2017

page(s)

86-91

1 reference

Evaluation of intraocular pharmacokinetics and toxicity of prinomastat (AG3340) in the rabbit

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Human T lymphocytes express a member of the Matrix Metalloproteinase gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Expression of matrix metalloproteinases by human plasma cells and B lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Preclinical and clinical studies of MMP inhibitors in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

MMP-9 is predominantly expressed in epithelioid and not spindle cell uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

A comparison of ocular melanocyte and uveal melanoma cell invasion and the implication of alpha1beta1, alpha4beta1 and alpha6beta1 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Heterotransplantation of human uveal melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Relative importance of quantifying area and vascular patterns in uveal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Evaluation of the human choroidal melanoma rabbit model for studying microcirculation patterns with confocal ICG and histology

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

A simple noncontact wide-angle fundus photography procedure for clinical and research use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

The effect of prinomastat (AG3340), a potent inhibitor of matrix metalloproteinases, on a subacute model of proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on posttraumatic proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Current approaches to the diagnosis and management of choroidal melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B).

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Induction of metalloproteinase activity in human T-lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Broad antitumor and antiangiogenic activities of AG3340, a potent and selective MMP inhibitor undergoing advanced oncology clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

Expression of integrins, degradative enzymes and their inhibitors in uveal melanoma: differences between in vitro and in vivo expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

A new matrix metalloproteinase inhibitor SI-27 induces apoptosis in several human myeloid leukemia cell lines and enhances sensitivity to TNF alpha-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FCEYR.24.2.86.8159

10.1076/CEYR.24.2.86.8159

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference